$-0.01
(Market cap
$2 Mln
Revenue (TTM)
$16 Mln
P/E Ratio
--
P/B Ratio
29.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-41 %
-
ROCE
-- %
-
Industry P/E
51.35
-
EV/EBITDA
18.1
-
Debt to Equity
-0.8
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
20,074,675
10 Years Aggregate
CFO
$-62.91 Mln
EBITDA
$-48.27 Mln
Net Profit
$-101.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biotricity Inc (BTCY)
| -65.3 | -19.8 | -58.1 | -79.3 | -67.5 | -65.9 | -40.0 |
|
BSE Sensex*
| -8.3 | 0.7 | 1.0 | -4.0 | 5.5 | 8.2 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Biotricity Inc (BTCY)
| 3.2 | -75.4 | -57.2 | -88.7 | 439.3 | 17.1 | 31.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biotricity Inc (BTCY)
|
0.1 | 2.3 | 16.4 | -2.1 | 7.6 | -- | -- | 29.9 |
| 107.3 | 179,511.3 | 46,585.0 | 5,425.0 | 13.3 | 20.8 | 32.6 | 3.4 | |
| 39.8 | 1,774.5 | 569.6 | 10.6 | 3.0 | 2.1 | 166.9 | 3.4 | |
| 199.1 | 135,324.8 | 25,107.0 | 4,004.0 | 15.4 | 7.6 | 31.9 | 2.4 | |
| 83.7 | 47,578.4 | 6,512.3 | 1,004.9 | 13.8 | 19.5 | 49.2 | 4.7 | |
| 361.8 | 120,918.8 | 11,034.4 | 3,138.8 | 33.8 | 17.3 | 38 | 6.5 | |
| 576.4 | 212,686.4 | 46,336.0 | 6,978.0 | 18.6 | 13.1 | 28.9 | 3.8 | |
| 71.0 | 213.8 | 36.1 | 10.5 | 33.9 | 8.7 | 20.5 | 1.7 | |
| 337.0 | 25,025.8 | 3,326.5 | 564.9 | 15.3 | 18.3 | 47.8 | 8.5 |
Shareholding Pattern
View DetailsAbout Biotricity Inc (BTCY)
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and... post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California. Read more
-
Founder, President, CEO & Chairman
Dr. Waqaas Al-Siddiq Ph.D.
-
Founder, President, CEO & Chairman
Dr. Waqaas Al-Siddiq Ph.D.
-
Headquarters
Redwood City, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Biotricity Inc (BTCY)
What is the current share price of Biotricity Inc (BTCY) Today?
The share price of Biotricity Inc (BTCY) is $0.10 (NASDAQ) as of 27-Jul-2026 09:30 EDT. Biotricity Inc (BTCY) has given a return of -67.53% in the last 3 years.
What is the current PB & PE ratio of Biotricity Inc (BTCY)?
Since, TTM earnings of Biotricity Inc (BTCY) is negative, P/E ratio is not available.
The P/B ratio of Biotricity Inc (BTCY) is 29.92 times as on 24-Jul-2026, a 775 premium to its peers’ median range of 3.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
-2.65
|
-0.19
|
|
2025
|
-1.09
|
-0.31
|
|
2024
|
-0.95
|
-0.44
|
|
2023
|
-0.22
|
-0.21
|
|
2022
|
-0.62
|
-8.47
|
What is the 52 Week High and Low of Biotricity Inc (BTCY)?
The 52-week high and low of Biotricity Inc (BTCY) are Rs 0.75 and Rs 0.09 as of 29-Jul-2026.
What is the market cap of Biotricity Inc (BTCY)?
Biotricity Inc (BTCY) has a market capitalisation of $ 2 Mln as on 24-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Biotricity Inc (BTCY)?
Before investing in Biotricity Inc (BTCY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.